Search Within

Mary Louise Keohan

  1. "Molecular Imaging and Therapy Service"
Formats
  1. Journal Article (14)
  2. Meeting Abstract (13)
Groups
  1. Body Imaging Service (27)
  2. Department of Medicine (27)
  3. Molecular Imaging and Therapy Service (27)
  4. Radiology, Department of (27)
  5. Sarcoma Service (27)
  6. Solid Tumor Oncology Division (27)

More Groups

People
  1. Mark Dickson (26)
  2. William Tap (26)
  3. Mrinal Gounder (25)
  4. Sandra D'Angelo (25)
  5. Ping Chi (23)
  6. Li-Xuan Qin (21)

More People

Years
  1. 2024 (1)
  2. 2023 (2)
  3. 2022 (5)
  4. 2021 (2)
  5. 2020 (3)
  6. 2019 (5)

More Years

Publications
  1. Journal of Clinical Oncology (14)
  2. Clinical Cancer Research (4)
  3. The Oncologist (2)
  4. Annals of Oncology (1)
  5. Investigational New Drugs (1)
  6. JAMA Oncology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (15)
  2. American Association for Cancer Research (4)
  3. Oxford University Press (3)
  4. American Medical Association (1)
  5. Hindawi Publishing Corporation (1)
  6. Nature Publishing Group (1)

More Publishers

Results (27)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Therapy-induced senescence contributes to the efficacy of abemaciclib in patients with dedifferentiated liposarcoma
    Journal Article

    Gleason, C. E.; Dickson, M. A.; Klein, M. E.; Antonescu, C. R.; Gularte-MeĢrida, R.; Benitez, M.; Delgado, J. I.; Kataru, R. P.; Tan, M. W. Y.; Bradic, M.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • A phase II study of talimogene laherparepvec (T-VEC) and pembrolizumab in patients with advanced sarcoma: Results of expansion cohorts
    Meeting Abstract

    Kelly, C. M.; Avutu, V.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Rosenbaum, E.; Cordover, E.; Ariyan, C. E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase II study of epacadostat and pembrolizumab in patients with advanced sarcoma
    Journal Article

    Kelly, C. M.; Qin, L. X.; Whiting, K. A.; Richards, A. L.; Avutu, V.; Chan, J. E.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • DICER1-associated anaplastic sarcoma of the kidney with coexisting activating PDGFRA D842V mutations and response to targeted kinase inhibitors in one patient
    Journal Article

    Antonescu, C. R.; Reuter, V. E.; Keohan, M. L.; Hwang, S.; Chi, P.
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Pilot study of bempegaldesleukin in combination with nivolumab in patients with metastatic sarcoma
    Journal Article

    D'Angelo, S. P.; Richards, A. L.; Conley, A. P.; Woo, H. J.; Dickson, M. A.; Gounder, M.; Kelly, C.; Keohan, M. L.; Movva, S.; Thornton, K.; more...
    Nature Communications (2022)

    Fulltext@MSK | Save
  • Phase Ib trial of the combination of imatinib and binimetinib in patients with advanced gastrointestinal stromal tumors
    Journal Article

    Chi, P.; Qin, L.; Camacho, N.; Kelly, C. M.; D'Angelo, S. P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Nacev, B. A.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Phase II trial of imatinib plus binimetinib in patients with treatment-naive advanced gastrointestinal stromal tumor
    Journal Article

    Chi, P.; Qin, L. X.; Nguyen, B.; Kelly, C. M.; D'Angelo, S. P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Nacev, B. A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Long-term follow-up and patterns of response, progression, and hyperprogression in patients after PD-1 blockade in advanced sarcoma
    Journal Article

    Klemen, N. D.; Hwang, S.; Bradic, M.; Rosenbaum, E.; Dickson, M. A.; Gounder, M. M.; Kelly, C. M.; Keohan, M. L.; Movva, S.; Thornton, K. A.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • A phase 1b study of avelumab plus DCC-3014, a potent and selective inhibitor of colony stimulating factor 1 receptor (CSF1R), in patients with advanced high-grade sarcoma
    Meeting Abstract

    Rosenbaum, E.; Movva, S.; Kelly, C. M.; Dickson, M. A.; Keohan, M. L.; Gounder, M. M.; Thornton, K. A.; Chi, P.; Chan, J. E.; Nacev, B.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Biomarkers of response and hyperprogression in patients with sarcoma treated with checkpoint blockade
    Meeting Abstract

    Klemen, N. D.; Hwang, S.; Bradic, M.; Rosenbaum, E.; Dickson, M.; Gounder, M.; Kelly, C. M.; Keohan, M. L.; Movva, S.; Thornton, K.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save